Locum Consultant Oncoplastic Breast Surgeon inWolverhampton inWolverhampton PUBLISHED 31 OCT 2024
The Royal Wolverhampton NHS Trust rAEylxrw
Stand by, we'll show you...
The Royal Wolverhampton Hospitals NHS Trust wish to appoint a suitably experienced and motivated Locum Consultant Oncoplastic Breast Surgeon to join our Breast Team.
Currently we have five breast surgeons (four surgeons have a special interest in oncoplastic breast surgery).
The successful candidate will have a special interest in breast and oncoplastic surgery. The Trust has two sites for out-patient and elective surgical activity at New Cross Hospital and Cannock Chase Hospital. The successful candidate will be expected to participate in delivering services on both sites.
In conjunction with Consultant and Senior colleagues, to provide a service in the Breast Team.
To provide cover for Consultant and Senior colleagues in respect of periods of leave.
To ensure that there are adequate arrangements for hospital staff involved in the care of your patients to be able to contact you when necessary.
The post-holder will contribute to the General Surgery service, including elective theatres and clinics.
About usAlong with the Consultants the team has two Specialty Doctors, one Speciality Trainee (Deanery), two Trust Clinical Fellows, one FY2 and two FY1 Trainees. There is a Consultant Nurse and five Breast Care Nurses.
As a tertiary cancer centre, the breast team treats circa 500 new breast cancers per annum, participate in the Breast Screening Service and carry out approximately 180 oncoplastic procedures per year.
Apart from routine breast operations and sentinel node biopsy we perform a wide range of oncoplastic procedures. These include therapeutic mammoplasty including contralateral breast reduction, lipomodelling, Skin and nipple sparing mastectomy, skin reducing mastectomy, Implant based immediate breast reconstruction including use of acellular dermal matrix and Extended Latissimus dorsi flap reconstruction and perforator flaps (e.g. LICAP flap).
The team is enthusiastic in audit and clinical research and have had several presentations in national and international meetings and publications in peer reviewed journals. The breast team are also actively involved in recruiting patients for national trials. The team has organised National meetings in Innovation in Breast surgery for two consecutive years before COVID. The Breast consultants are involved in regional and national roles in surgical training and Association of Breast Surgery.
The Royal Wolverhampton Hospitals NHS Trust wish to appoint a suitably experienced and motivated Locum Consultant Oncoplastic Breast Surgeon to join our Breast Team.
Currently we have five breast surgeons (four surgeons have a special interest in oncoplastic breast surgery).
The successful candidate will have a special interest in breast and oncoplastic surgery. The Trust has two sites for out-patient and elective surgical activity at New Cross Hospital and Cannock Chase Hospital. The successful candidate will be expected to participate in delivering services on both sites.
In conjunction with Consultant and Senior colleagues, to provide a service in the Breast Team.
To provide cover for Consultant and Senior colleagues in respect of periods of leave.
To ensure that there are adequate arrangements for hospital staff involved in the care of your patients to be able to contact you when necessary.
The post-holder will contribute to the General Surgery service, including elective theatres and clinics.
About us
Along with the Consultants the team has two Specialty Doctors, one Speciality Trainee (Deanery), two Trust Clinical Fellows, one FY2 and two FY1 Trainees. There is a Consultant Nurse and five Breast Care Nurses.
As a tertiary cancer centre, the breast team treats circa 500 new breast cancers per annum, participate in the Breast Screening Service and carry out approximately 180 oncoplastic procedures per year.
Apart from routine breast operations and sentinel node biopsy we perform a wide range of oncoplastic procedures. These include therapeutic mammoplasty including contralateral breast reduction, lipomodelling, Skin and nipple sparing mastectomy, skin reducing mastectomy, Implant based immediate breast reconstruction including use of acellular dermal matrix and Extended Latissimus dorsi flap reconstruction and perforator flaps (e.g. LICAP flap).
The team is enthusiastic in audit and clinical research and have had several presentations in national and international meetings and publications in peer reviewed journals. The breast team are also actively involved in recruiting patients for national trials. The team has organised National meetings in Innovation in Breast surgery for two consecutive years before COVID. The Breast consultants are involved in regional and national roles in surgical training and Association of Breast Surgery.
Please wait...this will take a moment...